Compared to MS, NMOSD patients display elevated interleukin-6 and interleukin-17 levels in the CSF along with a higher proportion of circulating T helper 17 and interleukin-17-producing cytotoxic T cells [24,25]. The gene discussed is IL17A; the disease is myeloid sarcoma.